Practical Recommendations for the Management of Diabetes in Patients with COVID-19

Depending on the global region, 20–50% of patients in the coronavirus disease 2019 (COVID-19) pandemic had diabetes. An international panel of experts in the field of diabetes and endocrinology – including researchers from the German Center for Diabetes Research (DZD) – provides some guidance and practical recommendations for the management of diabetes during the pandemic.


The researchers have compiled a simple flowchart for the metabolic screening and management of patients with COVID-19 and diabetes or at risk for metabolic disease. This includes recommendations regarding both the need for primary prevention of diabetes as well as the avoidance of severe sequelae of diabetes triggered by unidentified or poorly managed diabetes.

Furthermore, special considerations on anti-diabetes drugs commonly used in patients with type 2 diabetes in view of COVID-19 are presented in the panel.

Original publication:
Bornstein et al: Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020 Apr 23. pii: S2213-8587(20)30152-2. DOI: 10.1016/S2213-8587(20)30152-2.